Related Experiment Video
Updated: Oct 2, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
Potentiation of nitric oxide-induced apoptosis in p53-/- vascular smooth muscle cells
Melina R Kibbe1, Jianrong Li, Suhua Nie
1Department of Surgery, University of Pittsburgh, 677 Scaife Hall, Pittsburgh, PA 15261, USA. kibbemr@msx.upmc.edu
Abstract:
The functional role of p53 in nitric oxide (NO)-mediated vascular smooth muscle cell (VSMC) apoptosis remains unknown. In this study, VSMC from p53-/- and p53+/+ murine aortas were exposed to exogenous or endogenous sources of NO. Unexpectedly, p53-/- VSMC were much more sensitive to the proapoptotic effects of NO than were p53+/+ VSMC. Furthermore, this paradox appeared to be specific to NO, because other proapoptotic agents did not demonstrate this differential effect on p53-/- cells. NO-induced apoptosis in p53-/- VSMC occurred independently of cGMP generation. However, mitogen-activated protein kinase (MAPK) pathways appeared to play a significant role. Treatment of the p53-/- VSMC with S-nitroso-N-acetylpenicillamine resulted in a marked activation of p38 MAPK and, to a lesser extent, of c-Jun NH(2)-terminal kinase, mitogen-activated protein kinase kinase (MEK) 1/2, and p42/44 (extracellular signal-regulated kinase, ERK). Furthermore, basal activity of the MEK-p42/44 (ERK) pathway was increased in the p53+/+ VSMC. Inhibition of p38 MAPK with SB-203580 or of MEK1/2 with PD-98059 blocked NO-induced apoptosis. Therefore, p53 may protect VSMC against NO-mediated apoptosis, in part, through differential regulation of MAPK pathways.
Insights
The tumor suppressor p53 normally protects vascular smooth muscle cells (VSMC) from nitric oxide (NO)-induced cell death. Loss of p53 increases VSMC sensitivity to NO-induced apoptosis, mediated by mitogen-activated protein kinase (MAPK) pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Cardiovascular Research
Background:
- The role of the p53 tumor suppressor in nitric oxide (NO)-mediated apoptosis of vascular smooth muscle cells (VSMC) is not well understood.
- Nitric oxide plays a critical role in vascular homeostasis and disease.
Purpose of the Study:
- To investigate the functional role of p53 in NO-mediated VSMC apoptosis.
- To elucidate the signaling pathways involved in this process.
Main Methods:
- Vascular smooth muscle cells (VSMC) were isolated from p53 knockout (p53-/-) and wild-type (p53+/+) murine aortas.
- Cells were exposed to exogenous or endogenous sources of NO.
- Mitogen-activated protein kinase (MAPK) activation and apoptosis were assessed.
- Specific MAPK inhibitors were used to block NO-induced apoptosis.
Main Results:
- p53-/- VSMC exhibited significantly higher sensitivity to NO-induced apoptosis compared to p53+/+ VSMC.
- This effect was specific to NO and not observed with other proapoptotic agents.
- NO-induced apoptosis in p53-/- VSMC occurred independently of cyclic guanosine monophosphate (cGMP) generation.
- NO treatment markedly activated p38 MAPK, c-Jun NH(2)-terminal kinase, MEK1/2, and ERK pathways in p53-/- VSMC.
- Basal activity of the MEK-ERK pathway was elevated in p53+/+ VSMC.
- Inhibition of p38 MAPK or MEK1/2 abolished NO-induced apoptosis.
Conclusions:
- p53 acts as a protective factor against NO-mediated apoptosis in VSMC.
- This protection is, in part, achieved through the differential regulation of MAPK signaling pathways.
- These findings reveal a novel mechanism by which p53 influences vascular cell fate in response to NO.
Related Concept Videos
Nitric Oxide Signaling Pathway
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
